Daniel R. Omstead, President at TEKLA LIFE SCIENCES INVESTORS (HQL), bought 8,300 shares at $13.27 ($110K) on 2020-03-17, disclosed to the SEC on 2020-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HQL | BUY | 2023-09-20 | $152K | — | Filing → |
| HQH | BUY | 2023-09-20 | $151K | — | Filing → |
| HQL | BUY | 2021-08-12 | $277K | — | Filing → |